SCMP: Leaky jabs will struggle against the Omicron variant and it will take months to develop a new shot that works, at least according to the head of US vaccine manufacturer Moderna has told the Financial Times. It sounds like Big Pharma is not done squeezing money from this so-called pandemic. Even though the new variant isn't dangerous, Moderna and other companies want to make sure you have a needle in your arm every few months, so they get a never-ending flow of cash into their pockets.
top of page
bottom of page